WHY WAISMAN?
Full Support from Process Development to IND Filing
Accelerating your Move from Benchtop to Clinic
Ready to Partner for Success
Collaborative and Flexible Approach
Phacilitate 2012 Washington Forum (Jan 30-Feb1)
Waisman Biomanufacturing will be attending Phacilitate 2012 - Cell & Gene Therapy, Washington Vaccine and Protein Therapeutics Forums. Come to Booth #36 to learn how WB can help meet your GMP production needs.
Learn MorePlasmid DNA
Production
- High yield fermentation
- No enzymes or organic solvents
- Scalable production process
- Multi-gram capacity
- Direct injection or ex-vivo applications
Recombinant Protein Production
- Bacterial / mammalian hosts
- 30L fermentation / cell culture
- Cell harvest by centrifuge or filtration
- Protein refolding
- Scalable downstream processing
Cell Therapeutics Production
- Suspension / adherent cell bank capabilities
- Master / working bank options
- Large scale bioreactor / multitray production
- Vial / cryobag formats
- Control Rate Freezer cryopreservation
Viral Vector / Vaccine Production
- Envelope / Non-envelope viruses
- DNA / RNA viruses
- 35L bioreactor / multitray formats
- Disposable/scalable chromotography
- In house reference standards
Aseptic
Fill / Finish
- Semi-automated dispensing / crimping
- Full environmental / personnel monitoring
- Vial format 2000 unit capacity
- Bag format available
- Validation by annual Process Qualification